BR112013016701A2 - métodos para tratar a taquicardia e/ou controlar a frequência cardíaca enquanto minimiza e/ou controla a hipotensão. - Google Patents

métodos para tratar a taquicardia e/ou controlar a frequência cardíaca enquanto minimiza e/ou controla a hipotensão.

Info

Publication number
BR112013016701A2
BR112013016701A2 BR112013016701A BR112013016701A BR112013016701A2 BR 112013016701 A2 BR112013016701 A2 BR 112013016701A2 BR 112013016701 A BR112013016701 A BR 112013016701A BR 112013016701 A BR112013016701 A BR 112013016701A BR 112013016701 A2 BR112013016701 A2 BR 112013016701A2
Authority
BR
Brazil
Prior art keywords
controlling
minimizing
methods
heart rate
hypotension
Prior art date
Application number
BR112013016701A
Other languages
English (en)
Portuguese (pt)
Inventor
Rabinow Barrett
Mckee Jeff
Original Assignee
Baxter Healthcare Sa
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare Sa, Baxter Int filed Critical Baxter Healthcare Sa
Publication of BR112013016701A2 publication Critical patent/BR112013016701A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112013016701A 2011-01-27 2012-01-26 métodos para tratar a taquicardia e/ou controlar a frequência cardíaca enquanto minimiza e/ou controla a hipotensão. BR112013016701A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161436992P 2011-01-27 2011-01-27
PCT/US2012/022696 WO2012103314A1 (en) 2011-01-27 2012-01-26 Methods of treating tachycardia and/or controlling heart rate while minimizing and/or controlling hypotension

Publications (1)

Publication Number Publication Date
BR112013016701A2 true BR112013016701A2 (pt) 2017-07-04

Family

ID=45567141

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013016701A BR112013016701A2 (pt) 2011-01-27 2012-01-26 métodos para tratar a taquicardia e/ou controlar a frequência cardíaca enquanto minimiza e/ou controla a hipotensão.

Country Status (10)

Country Link
US (2) US8686036B2 (https=)
EP (1) EP2667867B1 (https=)
JP (1) JP2014505074A (https=)
KR (1) KR20140034729A (https=)
CN (1) CN103338763A (https=)
AU (1) AU2012211318C1 (https=)
BR (1) BR112013016701A2 (https=)
CA (1) CA2825311A1 (https=)
MX (1) MX2013008713A (https=)
WO (1) WO2012103314A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103347513A (zh) 2011-01-27 2013-10-09 巴克斯特国际公司 (s)-艾司洛尔用于控制与心脏病治疗相关的静脉刺激的应用
RU2613564C1 (ru) * 2015-12-02 2017-03-17 федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Западный государственный медицинский университет имени И.И. Мечникова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СЗГМУ им. И.И. Мечникова Минздрава России) Способ прогнозирования интраоперационной артериальной гипотензии при проведении анестезии

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179808B1 (en) 1984-04-09 1991-10-30 The Du Pont Merck Pharmaceutical Company Pharmaceutical composition suitable for treatment or prophylaxis of cardiac disorders
EP0248879A4 (en) * 1985-12-04 1990-02-26 Du Pont PRODUCTION OF ARYLOXYPROPANOLAMINES AND ARYLÄTHANOLAMINES.
JP2521317B2 (ja) * 1986-09-02 1996-08-07 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー ｄｌ―メチル３―［４―（２―ヒドロキシ―３―イソプロピルアミノ）プロポキシ］フエニルプロピオネ―ト［（ｄｌ―エスモロ―ル）］の分割
US4857552A (en) 1988-06-08 1989-08-15 E. I. Du Pont De Nemours And Co. Stable pharmaceutical composition
US5849843A (en) 1993-11-16 1998-12-15 Baxter International Inc. Polymeric compositions for medical packaging and devices
US5998019A (en) 1993-11-16 1999-12-07 Baxter International Inc. Multi-layered polymer structure for medical products
US5977409A (en) * 1997-04-15 1999-11-02 University Of Toledo Method of using α-substituted benzylamine chiral auxiliary synthetic reagents
TWI277414B (en) * 2001-01-12 2007-04-01 Baxter Int Esmolol formulation
US6310094B1 (en) 2001-01-12 2001-10-30 Baxter International Inc. Ready-to-use esmolol solution
EP1652533B2 (en) * 2003-08-08 2014-11-19 Ono Pharmaceutical Co., Ltd. Heart-slowing drug containing short-acting beta-blocker as the active ingredient
US20080293814A1 (en) 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
CN101323580A (zh) 2008-07-25 2008-12-17 河北科技大学 手性芳氧丙醇胺类化合物及其盐的合成方法
CN101881755B (zh) 2009-05-04 2013-05-29 南京海辰药业有限公司 通过高效液相色谱法检测盐酸艾司洛尔光学异构体的方法
CN101891636A (zh) 2009-05-21 2010-11-24 南京海辰药业有限公司 制备盐酸艾司洛尔光学异构体的新方法
CN102106846A (zh) 2009-12-23 2011-06-29 南京海辰药业有限公司 左旋盐酸艾司洛尔药物组合物及其制备方法
CN103347513A (zh) 2011-01-27 2013-10-09 巴克斯特国际公司 (s)-艾司洛尔用于控制与心脏病治疗相关的静脉刺激的应用

Also Published As

Publication number Publication date
US9084763B2 (en) 2015-07-21
MX2013008713A (es) 2013-08-29
CA2825311A1 (en) 2012-08-02
KR20140034729A (ko) 2014-03-20
EP2667867A1 (en) 2013-12-04
EP2667867B1 (en) 2015-05-27
WO2012103314A1 (en) 2012-08-02
US20140066503A1 (en) 2014-03-06
US20120302637A1 (en) 2012-11-29
AU2012211318C1 (en) 2016-08-04
CN103338763A (zh) 2013-10-02
AU2012211318B2 (en) 2016-01-28
US8686036B2 (en) 2014-04-01
JP2014505074A (ja) 2014-02-27
AU2012211318A1 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
LT3406251T (lt) Piruvatkinazės aktyvatoriai, skirti panaudoti terapijai
BR112014002174A2 (pt) estrutura de válvula cardíaca, estrutura de válvula cardíaca em múltiplas-lâminas e método para fabricar uma estrutura de válvula cardíaca
BR112015003846A2 (pt) aparelho flexível, e método para controlar um aparelho flexível
EP2765954A4 (en) POLYMER HEART FLAP
BR112013023277A2 (pt) métodos de tratamento de câncer usando 3-(5-amino-2-metil-4-oxo-4h-quinazolin-3-il)-piperidibna-2,6-diona
BR112014004182A2 (pt) métodos para tratar a hepatite c, para tratamento contra o vírus da hepatite c, e para prevenir ou tratar a hepatite c, e, composição
LT3395357T (lt) Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
BR112014004287A2 (pt) curativo para ferimento, método para preparar um curativo para ferimento e método para tratar um ferimento
HUE046544T2 (hu) Eljárások Hepatitis C kezelésére
BR112014029531A2 (pt) composto de piridina, composição e método para controlar vegetação indesejada
BR112015002739A2 (pt) métodos para intensificar, melhorar ou sustentar saúde e/ou função cognitiva em mamíferos, e para tratar ou prevenir um declínio em saúde e/ou função cognitiva em mamíferos
DK2767141T3 (da) Elektrisk varmesystem, et styrehoved og en opvarmningsvæske
BR112014010195A2 (pt) método, e, fluido
DE102012017152A8 (de) Ansteuerverfahren und Bildschirm, welcher das Verfahren nutzt.
BR112013023142A2 (pt) método de tratamento de cabelos
BR112014031693A2 (pt) método, e, ferramenta.
NO20120939A1 (no) Pulsbredderegulerende ventil
BR112014033074A2 (pt) veículo, e, método para controlar um veículo
BR112014024415A2 (pt) “composição, processo para preparar a composição e método para controlar fungos fitopatogênicos”
FR2996109B1 (fr) Applicateur chauffant.
EP2664798A4 (en) LIQUIDITY DRIVE UNIT AND CONTROL PROGRAM FOR THE LIQUIDITY DRIVE UNIT
BR112014005761A2 (pt) complexo de catalisador de irídio, composição de catalisador, e, método de desidrogenação de alcanos
BR112014012759A8 (pt) composto, composição e método para tratamento
SG2014011035A (en) Toll-computation device, control method, and program
BR112014003003A2 (pt) compostos, respectivos usos e processos para tratar ou prevenir infecção viral

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2447 DE 28-11-2017 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.